Quantcast
Last updated on April 16, 2014 at 1:21 EDT

Latest Kidney transplantation Stories

2013-06-04 12:27:59

Language Enables Health Plans to Reduce Dialysis Costs Up to 90% KING OF PRUSSIA, Pa., June 4, 2013 /PRNewswire/ -- DialysisPPO, founded in 2006 to help employer-group health plans ("EGHPs") manage the high cost of chronic, long-term dialysis - typically for the treatment of End-Stage Renal Disease ("ESRD") - announced today that the United States Patent and Trademark Office (USPTO) issued a patent covering our dialysis cost containment solution that limits exposure to dialysis...

2013-06-02 23:03:34

Kidney Disease Solution created by Duncan Capicchiano is a new program that provides people with an innovative kidney disease treatment plan. A full Kidney Disease Solution review on the site Vkool.com indicates if the program is worth buying. Seattle, Wa (PRWEB) June 02, 2013 Kidney Disease Solution developed by Duncan Capicchiano is a new kidney disease treatment program that instructs people how to beat their kidney disease naturally and fast. This program provides people with...

2013-05-28 11:34:06

BIDMC research suggests that improved communication could help with end of life decision making In any given year, 400,000 Americans suffering from end-stage kidney disease will undergo dialysis, and as many as 20 to 25 percent of those dialysis patients will die, a statistic comparable to many types of cancer. But while cancer doctors may be more accustomed to talking with patients about the likely course of their disease, a new study from Beth Israel Deaconess Medical Center finds that...

2013-05-21 16:27:48

HORSHOLM, Denmark, May 21, 2013 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) today announced that the European Medicines Agency (EMA) accepted for review the company's Marketing Authorization Application (MAA) to market LCP-Tacro for the prevention of organ rejection in kidney transplant patients in the European Union. Veloxis expects the decision from the European Union in 2014. For Investor and media contact: John Weinberg, M.D. EVP & Chief Commercial Officer Phone: +1 732...

2013-05-20 04:20:45

Data from the STRATO Study Presented at the 13th American Transplant Congress HORSHOLM, Denmark, May 20, 2013 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) today announced that data from the STRATO study demonstrates the potential for LCP-Tacro(TM) to improve tacrolimus-induced tremors in stable kidney transplant patients. The study, Switching STudy of Kidney TRansplant PAtients with Tremor to LCP-TacrO(TM) (STRATO) clinical trial, was presented at the 13(th) American...

2013-05-16 10:49:38

Obese patients who received robotic kidney transplants had fewer wound complications than patients who received traditional “open” transplant surgery, according to surgeons at the University of Illinois Hospital & Health Sciences System. The findings should allow more obese patients to receive kidney transplants. Patients with a body mass index (BMI) greater than 35 who have end-stage kidney disease are often denied transplantation, and patients with a BMI over 40 often...

2013-05-15 08:31:09

-- Phase 1 trial of Neo-Kidney Augment(TM) on track for initiation in Sweden in second quarter of 2013 and in U.S. in fourth quarter of 2013 -- WINSTON-SALEM, N.C., May 15, 2013 /PRNewswire/ -- Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today provided a business update and reported its financial results for the first quarter ended March 31, 2013. "We are very pleased to have achieved a significant milestone this quarter with the MPA approval for the Phase 1...

2013-05-06 11:47:44

In a study that included more than 20,000 patients, there was a significant decrease in the United States in mortality rates over time among children and adolescents initiating end-stage kidney disease treatment with dialysis between 1990 and 2010, according to a study in the May 8 issue of JAMA. The study is being released early online to coincide with its presentation at the Pediatric Academic Societies annual meeting. "Individuals with end-stage kidney disease (ESKD) face a...

2013-04-29 08:27:28

HORSHOLM, Denmark, April 29, 2013 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) today announced that it has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) seeking approval to market LCP-Tacro for the prevention of organ rejection in kidney transplant patients in the European Union. The MAA submission is based on the favorable results of the LCP-Tacro Phase III 3001 study in stable kidney transplant patients and data from an extensive...

2013-04-24 12:30:30

- U.S. FDA approves Investigational New Drug Application to begin U.S. clinical trials RESEARCH TRIANGLE PARK, N.C., April 24, 2013 /PRNewswire/ -- Humacyte, Inc., today announced the accomplishment of significant milestones in the clinical development of its innovative bioengineered blood vessel technology - the first off-the-shelf, human-derived, artificial blood vessels. The company received U.S. Food and Drug Administration (FDA) approval for an Investigational New Drug...


Latest Kidney transplantation Reference Libraries

2011-01-05 16:14:54

The BK virus, a member of the polyomavirus family, has no major consequences of infected except with those that are immunocomprimised or immunosuppressed. The virus was first isolated in 1971 from the urine sample of a renal transplant patient whose initials were B.K. Similar in genome sequences to the JCV virus they are most easily identified and differentiated from each other through serological tests using specific antibodies or through PCR based genotyping approach. Most people are...

More Articles (1 articles) »